Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins
- PMID: 29441425
- PMCID: PMC6021463
- DOI: 10.1007/s00018-018-2773-4
Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins
Abstract
The isolation of extracellular vesicles (EVs) from blood is of great importance to understand the biological role of circulating EVs and to develop EVs as biomarkers of disease. Due to the concurrent presence of lipoprotein particles, however, blood is one of the most difficult body fluids to isolate EVs from. The aim of this study was to develop a robust method to isolate and characterise EVs from blood with minimal contamination by plasma proteins and lipoprotein particles. Plasma and serum were collected from healthy subjects, and EVs were isolated by size-exclusion chromatography (SEC), with most particles being present in fractions 8-12, while the bulk of the plasma proteins was present in fractions 11-28. Vesicle markers peaked in fractions 7-11; however, the same fractions also contained lipoprotein particles. The purity of EVs was improved by combining a density cushion with SEC to further separate lipoprotein particles from the vesicles, which reduced the contamination of lipoprotein particles by 100-fold. Using this novel isolation procedure, a total of 1187 proteins were identified in plasma EVs by mass spectrometry, of which several proteins are known as EV-associated proteins but have hitherto not been identified in the previous proteomic studies of plasma EVs. This study shows that SEC alone is unable to completely separate plasma EVs from lipoprotein particles. However, combining SEC with a density cushion significantly improved the separation of EVs from lipoproteins and allowed for a detailed analysis of the proteome of plasma EVs, thus making blood a viable source for EV biomarker discovery.
Keywords: Density cushion; Exosomes; Extracellular vesicles; Lipoproteins; Mass spectrometry; Plasma; Proteomics; Serum; Size-exclusion chromatography.
Conflict of interest statement
JL and SCJ have written several patents in the field of extracellular vesicles as therapeutics and are currently or have previously been employees of Codiak BioSciences Inc. CL and AC are co-inventors on a patent using extracellular vesicles as diagnostic tools in diseases. The other authors declare that there are no financial, personal, or professional interests that could be construed to have influenced the paper.
Figures






References
-
- Shelke GV, Jang SC, Yin Y, et al. Human mast cells release extracellular vesicle-associated DNA. Matters. 2016 doi: 10.19185/matters.201602000034. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources